Conor Barry

Conor Barry is a seasoned professional in the field of pharmaceutical research and development with extensive experience in leading scientific initiatives across multiple organizations. Currently serving as the Head of Development at Piramal Pharma Limited since August 2021, Conor is responsible for overseeing research and development projects, including CMC deliverables from pre-clinical to commercial stages. Prior to this, Conor held the position of Chief Scientific Officer at EnzBond Limited, contributing to the design of novel enzymes and proteins through advanced software platforms. Conor has also significantly impacted the industry while leading the Analytical Sciences department at AstraZeneca (Spirogen), focusing on antibody-drug conjugates. Academic credentials include a PhD in Organic Chemistry from the University of Bristol and a postgraduate diploma in Strategy & Innovation from Saïd Business School, University of Oxford.